Sun’s Generic Doxil Clears FDA; Janssen Uses Alternative Manufacturing Process
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approval of the first generic version of Janssen’s Doxil to curtail drug’s shortage; agency also permits Janssen to use an alternative manufacturing process.